Vital Thera receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immunic Inc (IMUX)
Assess today's live Immunic Inc (IMUX) share price, performance and insights using our live NASDAQ: IMUX stock exchange data.
Analyse the historical data and Immunic Inc share price performance charts on this page. Our technical summary section provides analysis on Immunic share price buy/sell indicators using real-time data (or discuss the Immunic (IMUX) stock price today with other investors in the Immunic NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IMUX share price (ISIN: US4525EP1011) to enhance your trading decisions with our free investment tools and resources.
What Is the Immunic Inc Share Price Today?
The Immunic share price today is 0.574.
What Is the Stock Symbol for Immunic Inc
The stock symbol (or 'ticker') for Immunic Inc is "IMUX."
What Stock Exchange Does Immunic Inc Trade On?
Immunic Inc is listed and trades on the NASDAQ stock exchange.
Is Immunic Inc a Good Stock to Buy?
Determining whether Immunic Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Immunic Inc share price performance charts on this page. Our technical summary section provides analysis on Immunic share price buy/sell indicators using real-time data (or discuss the Immunic (IMUX) stock price today with other investors in the Immunic NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IMUX share price (ISIN: US4525EP1011) to enhance your trading decisions with our free investment tools and resources.
What Is the Immunic Inc Share Price Today?
The Immunic share price today is 0.574.
What Is the Stock Symbol for Immunic Inc
The stock symbol (or 'ticker') for Immunic Inc is "IMUX."
What Stock Exchange Does Immunic Inc Trade On?
Immunic Inc is listed and trades on the NASDAQ stock exchange.
Is Immunic Inc a Good Stock to Buy?
Determining whether Immunic Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.567
0.615
52 wk Range
0.553
1.390
IMUX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5670.615
52 wk Range
0.5531.390
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMUX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.375
Upside
+836.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
- Vital Thera receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Immunic Inc For: 13 November
- Investing.com
- Vital Thera receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Immunic Inc For: 13 November
- Investing.com
- Vital Thera receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Vital Thera receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Immunic Company Profile
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
Compare IMUX to Peers and Sector
Metrics to compare | IMUX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMUXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −3.9x | −0.6x | |
PEG Ratio | −0.02 | 0.29 | 0.00 | |
Price/Book | 6.6x | 4.0x | 2.6x | |
Price / LTM Sales | - | 391.3x | 3.2x | |
Upside (Analyst Target) | - | 131.4% | 41.8% | |
Fair Value Upside | Unlock | −15.7% | 5.1% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.375
(+836.41% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.13 / -0.15
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Immunic (IMUX) Share Price Today?
The live Immunic share price today is 0.574
What Stock Exchange Does Immunic (IMUX) Trade On?
Immunic is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Immunic?
The stock symbol (also called a 'ticker') for Immunic is "IMUX."
What Is the Current Immunic Market Cap?
As of today, Immunic market capitalisation is 69.06M.
What Is Immunic's (IMUX) Earnings Per Share (TTM)?
The Immunic EPS is currently -0.78 (Trailing Twelve Months).
When Is the Next Immunic Earnings Date?
Immunic's next earnings report will be released on 19 Feb 2026.
Is IMUX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Immunic moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Immunic Stock Split?
Immunic has split 1 times. (See the IMUX stock split history page for full effective split date and price information.)
How Many Employees Does Immunic Have?
Immunic has 90 employees.
What is the current trading status of Immunic (IMUX)?
As of 24 Dec 2025, Immunic (IMUX) is trading at a price of 0.574, with a previous close of 0.603. The stock has fluctuated within a day range of 0.567 to 0.615, while its 52-week range spans from 0.553 to 1.390.
What Is Immunic (IMUX) Price Target According to Analysts?
The average 12-month price target for Immunic is USD5.375, with a high estimate of USD10 and a low estimate of USD3. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +836.41% Upside potential.
What Is the IMUX Premarket Price?
IMUX's last pre-market stock price is 0.615. The pre-market share volume is 15,320.000, and the stock has decreased by 0.012, or 1.990%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.